View Author
jtk -652 -652 hepg 2 cells tumour cells patient virus study infection hepatitis expression carcinoma tumour pseudotype hepatitis c patients dysplasia protein hcv genotype 1 effect concentration cancer coliti genotype treatment bcl-xl colon hepatitis c virus apoptosi caspase 3 entry sample hcv pseudotype virus hepatitis c inflammation safety inhibition placebo result staining 7 cells score development figure inhibitor pharmacokinetic volunteer netherland article 100 mg sequence cd 81 epithelial cells mucosa hcvpv epithelial envelope hepatocyte barrett caspase level immunohistochemical participant colon cancer nitric hcv replicon rna activity antiapoptotic proteins plasma tolerability center oxide dosing receptor antiapoptotic value adenocarcinoma target cells cell lines pattern epithelium dose level
3 Most Recent Publications
|
Verrazano narrows storm surge barrier: A Dutch vision
(Article)
Jansen, P.L.M. Dircke, P. |
2013-04-16
|
|
Safety and antiviral activity of JTK-652: A novel HCV infection inhibitor
(Article)
Bruijne, J. Bergmann, J.F. Schinkel, J. Reesink, H.W. Janssen, H.L.A. Weegink, C.J. Nieuwkerk, C.M.J. van Knegt, R.J. de Komoda, Y. Rooij, J.J.V.D.W. de Vliet, A.A. Jansen, P.L.M. Molenkamp, R. |
2010-10-08
|
|
Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis
(Article)
Woude, C.J. van der Moshage, H. Homan, M. Kleibeuker, J.H. Jansen, P.L.M. Dekken, H. van |
2005-01-01
|
